Co-Authors
This is a "connection" page, showing publications co-authored by Stephen Iwanowycz and Daping Fan.
Connection Strength
2.348
-
Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages. Mol Cancer Ther. 2016 08; 15(8):1931-42.
Score: 0.578
-
Emodin Bidirectionally Modulates Macrophage Polarization and Epigenetically Regulates Macrophage Memory. J Biol Chem. 2016 May 27; 291(22):11491-503.
Score: 0.572
-
Bone marrow deficiency of mRNA decaying protein Tristetraprolin increases inflammation and mitochondrial ROS but reduces hepatic lipoprotein production in LDLR knockout mice. Redox Biol. 2020 10; 37:101609.
Score: 0.192
-
Anticancer activity of emodin is associated with downregulation of CD155. Int Immunopharmacol. 2019 Oct; 75:105763.
Score: 0.180
-
Transcriptional factor EB regulates macrophage polarization in the tumor microenvironment. Oncoimmunology. 2017; 6(5):e1312042.
Score: 0.154
-
microRNA-155 deficiency impairs dendritic cell function in breast cancer. Oncoimmunology. 2016; 5(11):e1232223.
Score: 0.148
-
Ursolic acid enhances macrophage autophagy and attenuates atherogenesis. J Lipid Res. 2016 06; 57(6):1006-16.
Score: 0.143
-
Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs. Breast Cancer Res Treat. 2014 Nov; 148(2):291-302.
Score: 0.129
-
MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth. Int J Cancer. 2015 Mar 15; 136(6):E602-13.
Score: 0.128
-
Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides. Exp Biol Med (Maywood). 2014 Aug; 239(8):1025-1035.
Score: 0.125